VA Healthcare & Services Contracts — September 22, 2026
The sole contract in this digest is a $240.6 million firm-fixed-price delivery order awarded to QTC Medical Services Inc., a Leidos subsidiary, by the Department of Veterans Affairs (VA) for medical evaluation and screening services under NAICS 621111. This is a purely civilian award with zero defense-related exposure, reflecting the VA's sustained investment in healthcare delivery rather than technology or defense priorities. The contract's 97% outlay rate ($233.6 million of $240.6 million) signals near-complete funding utilization and strong execution, but the neutral signal strength (5/10) and lack of options or set-asides temper the investment significance. The highest-conviction signal is the competitive win for Leidos in the VA healthcare services market, though the one-year performance period (Oct 2023–Sep 2024) has already elapsed, making follow-on recompete activity the key forward-looking catalyst. Key risks include concentration in a single agency and the absence of growth options, while the watch item is the timing and outcome of the follow-on procurement after September 2024.